Kevin Herde - Net Worth and Insider Trading
Kevin Herde Net Worth
The estimated net worth of Kevin Herde is at least $42 dollars as of 2024-11-11. Kevin Herde is the Executive VP and CFO of Sorrento Therapeutics Inc and owns about 7,000 shares of Sorrento Therapeutics Inc (SRNE) stock worth over $42. Details can be seen in Kevin Herde's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kevin Herde has not made any transactions after 2017-02-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Kevin Herde
Kevin Herde Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kevin Herde owns 2 companies in total, including Sorrento Therapeutics Inc (SRNE) , and Maravai LifeSciences Holdings Inc (MRVI) .
Click here to see the complete history of Kevin Herde’s form 4 insider trades.
Insider Ownership Summary of Kevin Herde
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SRNE | Sorrento Therapeutics Inc | 2017-02-03 | Executive VP and CFO |
| MRVI | Maravai LifeSciences Holdings Inc | 2020-11-19 | Chief Financial Officer |
Kevin Herde Latest Holdings Summary
Kevin Herde currently owns a total of 1 stock. Kevin Herde owns 7,000 shares of Sorrento Therapeutics Inc (SRNE) as of February 3, 2017, with a value of $42.
Latest Holdings of Kevin Herde
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SRNE | Sorrento Therapeutics Inc | 2017-02-03 | 7,000 | 0.01 | 42 |
Holding Weightings of Kevin Herde
Kevin Herde Form 4 Trading Tracker
According to the SEC Form 4 filings, Kevin Herde has made a total of 0 transactions in Sorrento Therapeutics Inc (SRNE) over the past 5 years. The most-recent trade in Sorrento Therapeutics Inc is the acquisition of 3,000 shares on February 3, 2017, which cost Kevin Herde around $15,450.
Insider Trading History of Kevin Herde
- 1
Kevin Herde Trading Performance
GuruFocus tracks the stock performance after each of Kevin Herde's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kevin Herde is -62.75%. GuruFocus also compares Kevin Herde's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kevin Herde within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Kevin Herde's insider trading performs compared to the benchmark.
Performance of Kevin Herde
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -1.96 | | | | | |
| Relative Return to S&P 500(%) | -5.69 | | | | | |
Kevin Herde Ownership Network
Ownership Network List of Kevin Herde
Ownership Network Relation of Kevin Herde
Kevin Herde Owned Company Details
What does Sorrento Therapeutics Inc do?
Who are the key executives at Sorrento Therapeutics Inc?
Kevin Herde is the Executive VP and CFO of Sorrento Therapeutics Inc. Other key executives at Sorrento Therapeutics Inc include director & See Remarks Henry Ji , Chief Financial Officer Najjam Asghar , and See Remarks Jerome B Zeldis .
Sorrento Therapeutics Inc (SRNE) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Sorrento Therapeutics Inc (SRNE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sorrento Therapeutics Inc (SRNE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Sorrento Therapeutics Inc (SRNE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Sorrento Therapeutics Inc Insider Transactions
Kevin Herde Mailing Address
Above is the net worth, insider trading, and ownership report for Kevin Herde. You might contact Kevin Herde via mailing address: C/o Maravai Lifesciences Holdings, Inc., 10770 Wateridge Circle Suite 200, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
